MedPath

CONTROLLED MEDICATIONS LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

117

PPB:117

Drug Approvals

FECIBRAT TABLETS 145MG

Approval Date
May 28, 2025
PPB

FLUCONAZOLE CAPSULES 150MG

Approval Date
Mar 6, 2025
PPB

CETIRIZINE DIHYDROCHLORIDE TABLETS 10MG

Approval Date
May 9, 2024
PPB

NEXIJUB 20 GASTRO-RESISTANT TABLETS 20MG

Approval Date
May 9, 2024
PPB

NEXIJUB 40 GASTRO-RESISTANT TABLETS 40MG

Approval Date
May 9, 2024
PPB

MONTELUKAST CHEWABLE TABLETS 4MG

Approval Date
Apr 11, 2024
PPB

MONTELUKAST CHEWABLE TABLETS 5MG

Approval Date
Apr 11, 2024
PPB

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TABLETS 50MG/12.5MG

Approval Date
Oct 11, 2023
PPB

CLEDOMOX 50 TABLETS (VET)

Approval Date
Dec 30, 2021
PPB

JUBLEVET TABLETS 500MG

Approval Date
Jun 10, 2021
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.